Tolera Therapeutics Obtains $250,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fc705627-1680-49b7-ac99-3c64c1cd0cf4 - Date
9/17/2014 - Company Name
Tolera Therapeutics - Mailing Address
P.O. Box 970 Portage, MI 49081 USA - Company Description
Building upon research done at the University of Kentucky and the Cleveland Clinic, Tolera Therapeutics is developing and commercializing therapies for the immune suppression / modulation market with the goal of addressing unmet medical needs with safer, more targeted solutions to reduce the risk of serious and toxic side effects. - Website
http://www.tolera.com - Transaction Type
Debt - Transaction Amount
$250,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
